Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
Frontiers in PharmacologyBackgroundTeriparatide is approved for osteoporosis. Post-marketing surveillance is critical given its widespread use.ObjectiveTo investigate adverse events (AEs) associated with teriparatide using the FAERS database, compare association strengths for ...
Ming-Tao Wen +11 more
doaj +3 more sources
Pharmacovigilance of drug-induced cataract using the FDA Adverse Event Reporting System [PDF]
Scientific ReportsCataract is a leading cause of irreversible vision loss, particularly among the elderly, with drug-induced cataract being an underrecognized yet significant contributor to visual impairment.
Si-Yuan Hong +4 more
doaj +2 more sources
Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
Therapeutics and Clinical Risk Management, 2021 The purpose of this study was to investigate the adverse events (AEs) related to the use of off-label drugs.A cross-sectional study was carried out using available data pertaining to off-label drug were sourced from U.S. FDA spontaneous adverse drug reaction reporting database (FAERS) and Korea Adverse Event Reporting System database (KIDS-KD) for the ...
Nayoung Han, Jung Mi Oh, In-Wha Kim
openaire +6 more sources
Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System
Vaccines, 2022 In December 2020, the U.S. Food and Drug Administration licensed COVID-19 vaccines for emergency use authorization. We investigated the ocular adverse event reports in patients reported to the Vaccine Adverse Event Reporting System (VAERS) following ...
Cyril N. A. Nyankerh +2 more
doaj +1 more source
Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system
Expert Opinion on Drug Safety, 2023 Migraine has a high prevalence in the population and accounts for 12% of primary headaches. Ubrogepant is used for the treatment of acute migraine, and although some clinical trials have demonstrated the safety of Ubrogepant, its long-term safety in a large sample of the population remains to be investigated. We collected data from the US Food and Drug
Bing, Cao +5 more
openaire +2 more sources
Frontiers in Cardiovascular MedicineBackgroundAmlodipine, a widely prescribed clinical medication, is associated with adverse reactions that can impede the proper execution of treatment regimens.
Jiazhen Jiang +6 more
doaj +3 more sources
Adverse events associated with third-generation cephalosporins: Analysis of the FDA adverse event reporting system database. [PDF]
Medicine (Baltimore)Ahmed NJ.
europepmc +2 more sources
Status and Problems of Adverse Event Reporting Systems in Korean Hospitals [PDF]
Healthcare Informatics Research, 2010 ObjectivesThis study identifies the current status and problems of adverse event reporting system in Korean hospitals. The data obtained from this study will be used to raise international awareness and enable collaborative researches on patient safety ...
Jeongeun Kim +3 more
doaj +1 more source
Adverse event reporting systems and safer healthcare [PDF]
Quality and Safety in Health Care, 2009 At the heart of improvement and safety in healthcare is the now-familiar tenet that was espoused decades ago by Demming and paraphrased by Berwick.1 Need we repeat it again? Every defect should lead to improvement processes that make care safer. It is time to deliver on the promise of reporting systems in patient safety.
James B, Battles, David P, Stevens
openaire +2 more sources
Publicity and reports of behavioral addictions associated with dopamine agonists [PDF]
, 2015 Background The development of behavioral addictions (BAs) in association with dopamine agonists (DAs, commonly used to treat Parkinson’s disease) has been reported.
Gendreau, Katherine E., Potenza, Marc N.
core +1 more source